# OnCo record lymphoma-tx-immunoglobulin-replacement (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/lymphoma-tx-immunoglobulin-replacement/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "lymphoma-tx-immunoglobulin-replacement" ;
  schema:name "Immunoglobulin replacement after CAR-T, bispecifics and long anti-CD20 treatment"@en ;
  schema:alternateName "Hypogammaglobulinaemia"@en, "IVIG replacement"@en, "Secondary immunodeficiency"@en, "Subcutaneous immunoglobulin"@en ;
  schema:description "Treatments that remove B cells also remove the antibodies B cells make, and some people never make them again. When repeated chest and sinus infections follow, donated antibody given monthly by drip or weekly under the skin prevents them."@en ;
  schema:url <https://onco.cc/terms/lymphoma-tx-immunoglobulin-replacement/> ;
  schema:dateModified "2026-09-29"^^xsd:date ;
  schema:citation <https://b-s-h.org.uk/guidelines/> ;
  onco:cancers <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/follicular-lymphoma/>, <https://onco.cc/cancers/mantle-cell-lymphoma/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/car-t/>, <https://onco.cc/technologies/bispecific-antibody/> ;
  onco:drugs <https://onco.cc/drugs/human-normal-immunoglobulin/>, <https://onco.cc/drugs/rituximab/>, <https://onco.cc/drugs/obinutuzumab/>, <https://onco.cc/drugs/glofitamab/>, <https://onco.cc/drugs/epcoritamab/>, <https://onco.cc/drugs/mosunetuzumab/>, <https://onco.cc/drugs/axicabtagene-ciloleucel/>, <https://onco.cc/drugs/lisocabtagene-maraleucel/>, <https://onco.cc/drugs/tisagenlecleucel/> ;
  onco:terms <https://onco.cc/terms/lymphoma-tx-pjp-and-infection-prophylaxis/>, <https://onco.cc/terms/lymphoma-tx-crs-icans/> .